Altrubio Incis A Clinical Stage Biotechnology Company Based In San Franciscocaliforniawith Operations In Taipeitaiwanfounded In 2020The Company Is Dedicated To Developing Innovative Immune Modulating Therapeutics Aimed At Treating Immunological And Inflammatory Diseasesaltrubio Focuses On Creating First In Class Biologic Treatments That Address Immune System Dysregulationwith An Emphasis On Safer And More Durable Therapies The Company Operates A Global Research And Development Lab In Taipeifacilitating The Swift Translation Of Scientific Discoveries Into Clinical Applicationsaltrubio Fosters A Collaborative And Innovative Work Culturepromoting Employee Development And Offering Competitive Benefitstheir Teamwhich Spans Two Continentscombines Expertise In Immunology And Drug Development To Tackle Unmet Medical Needs In The Field
